Fayez Mohamood now serves as a product manager for BigDoor. Prior to BigDoor, Fayez formed a small startup named Twenty-Eight Wins, with a colleague. The product, Game Day Typhoon was a social fantasy sports game created exclusively for Facebook.
People on the Move
Scott Mullins joins BigDoor as a mobile product manager. Previously, Scott served as the senior director of business-to-business employment at RealNetworks and served as mobile manager principle solution architect at Photobucket.
Sean Zhong, who will serve as director of analytics at BigDoor, brings over eight years of experience in analyzing user data, having previously worked as lead software engineer and architect at Amazon and Big Fish Games.
Brett Goodwin, formerly of Isilon and RealNetworks, joins Skytap as VP marketing and business development. Brett will lead Skytap’s marketing strategy, development of business partnerships. Skytap provides cloud automation solutions. www.skytap.com
Medify, a leading provider of data-driven consumer health solutions, has appointed health care visionary Hal Andrews to their Board of Directors.
Cornerstone Advisors has hired Scott Dowling as Client Manager. Dowling brings over 22 years experience in investment management and financial analysis to his new role.
Noel Johnson joins Alliance as Managing Director for the Pacific Northwest. Previously with Trammell Crow in Portland, Mr. Johnson will grow and manage the Seattle & Portland markets for Alliance, as well as oversee all aspects of development.
Carter joins K&L Gates’ Seattle office as a partner in its corporate practice. He represents companies in an array of corporate areas, including formations, financings, mergers and acquisitions, technology transactions, and corporate governance.
Jessica Finn Coven, a clean energy and climate policy expert, was promoted to be Washington State Director for Climate Solutions. The group is a Northwest clean-energy economy nonprofit.
Acucela Inc., a Seattle-based clinical-stage biotech company focused on developing new treatments for blinding eye diseases, announces that Philip D. Rosenfeld, M.D., Ph.D., has joined the Clinical Advisory Board for ACU-4429, its lead compound.